Cargando…
LEISH2b - A phase 2b study to assess the safety, efficacy, and immunogenicity of the Leishmania vaccine ChAd63-KH in post-kala azar dermal leishmaniasis
Background: The leishmaniases are neglected tropical diseases caused by various Leishmania parasite species transmitted by sand flies. They comprise a number of systemic and cutaneous syndromes including kala-azar (visceral leishmaniasis, VL), cutaneous leishmaniasis (CL), and post-kala-azar dermal...
Autores principales: | Lacey, Charles, Musa, Ahmed, Khalil, El Tahir, Younis, Brima, Osman, Mohamed, Wiggins, Rebecca, Keding, Ada, Kaye, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213822/ https://www.ncbi.nlm.nih.gov/pubmed/37252616 http://dx.doi.org/10.12688/wellcomeopenres.17951.1 |
Ejemplares similares
-
Safety and immunogenicity of ChAd63-KH vaccine in post-kala-azar dermal leishmaniasis patients in Sudan
por: Younis, Brima M., et al.
Publicado: (2021) -
A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH
por: Osman, Mohamed, et al.
Publicado: (2017) -
Insights into the possible role of IFNG and IFNGR1 in Kala-azar and Post Kala-azar Dermal Leishmaniasis in Sudanese patients
por: Salih, Mohamed A M, et al.
Publicado: (2014) -
Kala-azar and Post–Kala-azar Dermal Leishmaniasis, Assam, India
por: Khan, Abdul Mabood, et al.
Publicado: (2014) -
Post kala-azar dermal leishmaniasis: an unresolved mystery
por: Mukhopadhyay, Debanjan, et al.
Publicado: (2014)